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Purpose of review 
This review examines the variation in clinical practice with regards to ultrasound 
estimation of fetal weight, as well as calculation of fetal weight centiles from 
population/customised fetal growth references or fetal growth standards. 
 
Recent findings 
Placental dysfunction is associated with fetal smallness from intrauterine malnutrition as 
well as fetal disability and even stillbirth from hypoxemia. Although estimating fetal weight 
can be done accurately, the issue of which fetal weight centile chart should be used 
continues to be a contentious topic. The arguments against local fetal growth charts 
based on national borders and customization for variables known to be associated with 
pathology are substantial. As for other human diseases such as hypertension and 
diabetes, there is a rationale for the use of an international fetal growth reference 
standard. Irrespective of the choice of fetal growth reference standard, a significant 
limitation of national SGA detection programs to prevent stillbirth is that the majority of 
stillborn infants at term were not SGA at the time of demise. 
 
Summary 
Placental dysfunction can present with SGA from malnutrition and/or stillbirth from 
hypoxemia depending on the gestational age of onset. Emerging data show that at term, 
fetal Doppler arterial redistribution is associated more strongly with perinatal death than 
fetal size. Properly conducted trials of the role for maternal characteristics, fetal size, 
placental biomarkers and Dopplers assessing fetal wellbeing are required urgently. 
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Stillbirth is a tragic event that has major psychological, social and economic effects on 
mothers, families and society in general [1]. The UK still has one of the highest rates of 
stillbirth in industrialized countries at 3.87 stillbirths per 1000 births – with two-thirds of 
stillbirths occurring near term at gestations beyond 34 weeks [2]. There is a long-
established association between fetal size and stillbirth, with the risk of stillbirth increasing 
for smaller relative fetal size or poor growth [3]. This observation has lent support to the 
argument that majority of stillbirth occurs as a consequence of placental dysfunction and 
therefore, they are potentially avoidable if delivery is effected before fetal demise. 
Therefore, most strategies for stillbirth prevention rely on ultrasound or serial fundal height 
measurement to screen for disturbances in fetal growth [4]. 
Fetal growth restriction (FGR) is defined as the failure of the fetus to reach its growth 
potential and is considered the commonest major complications of pregnancy [5]. It is a 
major risk factor for fetal stillbirth as well as other fetal comorbidities such as hypoxic 
ischemic encephalopathy and cerebral palsy [6-9]. However, as fetal growth potential is 
difficult to define, small for gestational age (SGA), defined as estimated fetal weight 
(EFW) below the 10th percentile, is commonly used as a proxy for FGR secondary to 
placental dysfunction. There is some retrospective evidence to suggest that antenatal 
detection of small for gestational age (SGA) fetuses could potentially halve the risk of 
stillbirths through appropriate antenatal surveillance and timely delivery [10, 11]. 
A policy of SGA detection first requires ultrasound estimation of fetal weight followed by 
calculation of the fetal weight centile by the use of a fetal weight reference chart or 
standard [12-14]. Currently, countless fetal weight calculators and fetal weight references 
exist which add to the clinical complexity and variability in outcomes. To add to the 
confusion, some academics have suggested customisation of fetal weight charts for 
certain maternal characteristics and others have challenged the effectiveness and 
unexpected negative outcomes related to a policy of screening for SGA fetuses [15-19]. 
This review outlines the background, benefits and limitations of health policies and 



































































FORMULAE TO ESTIMATE FETAL WEIGHT 
Ultrasound estimation of fetal weight is an essential prerequisite to calculating fetal weight 
centile for the identification of pregnancies at risk of SGA or large-for-gestational-age 
(LGA) birth. EFW may be derived from various fetal measurements or combinations of 
measurements of fetal head circumference (HC), biparietal diameter (BPD), femur length 
(FL) and abdominal circumference (AC) – with more than 50 publications providing 
formulae for clinical use. However, the majority of these formulae were derived from 
relatively small studies and most remain clinically unvalidated. Furthermore, there is no 
clinical consensus regarding the most appropriate formula to be used to calculate fetal 
weight. 
A recent prospective study utilised data from a cohort of 5163 pregnancies between 22–
43 weeks’ gestation, where a live birth occurred within two days of the ultrasound 
examination to evaluate the accuracy of existing formulae for estimating fetal weight [20]. 
The authors evaluated 70 different formulae – some using single fetal measurements and 
others utilising a composite of between two and four fetal biometric measures. The mean 
percentage error and absolute mean error was used to compare the accuracy of the 
various EFW formulae to predict actual birth weight (Figure 1) [21]. They demonstrated 
that the formula reported in 1985 by Hadlock et al., from measurements of HC, AC and 
FL, provides the most accurate prediction of birth weight and can be used for assessment 
of all babies, including those suspected to be either SGA or LGA [21]. 
A similar evaluation was carried out in twin pregnancy where the risk of SGA, FGR and 
adverse perinatal outcomes are higher [22]. This was a retrospective cohort study 
including 4280 singleton and 586 twin fetuses where routine ultrasound biometry was 
undertaken within 2 days of livebirth. Ultrasound estimation of fetal weight is less accurate 
in twin than in singleton pregnancies. Furthermore, formulae that include a combination 
of head, abdomen and femur measurements perform best in both singleton and twin 
pregnancies. As for singleton pregnancy, the best prediction of intertwin birth-weight 
discordance was achived using the Hadlock HC, AC and FL formula [21]. 
 


































































Only once fetal weight has been accurately calculated, can we use fetal weight or ‘growth’ 
charts to estimate the weight centile for a given gestation. There are several published 
charts that purport to correctly evaluate EFW centile varying by geographical location, 
clinical scenario (such as ethnicity, maternal stature, parity etc) or purporting to be an 
international reference standard. 
Local and national charts 
These are charts defined by the geography of a particular area (local) or country 
(national). The charts are typically constructed retrospectively from existing ultrasound 
biometry and birth weight data from the source population. The developers of such charts 
rationalise their use on the basis that there is recognised regional variation in child and 
adult stature, presumably due to ethnicity, social, economic and nutritional factors. These 
charts describe how babies in a particular geographical cohort ‘have grown’, but do not 
tell us what is clinically relevant - which is how a normal baby ‘should grow’ [23]. The main 
limitation with retrospectively constructed charts is that the pregnancy cohort contains 
hidden maternal and fetal morbidity which may have impaired fetal growth. Some charts 
have used retrospective ‘cleaning’ of the cohort data to overcome this limitation, but such 
an approach is typically incomplete and does not eliminate occult health problems. 
Another limitation of geographical charts is that, usually preterm births are used to 
establish normograms despite the finding that median BW for babies born preterm is 
substantially lower than median EFW [24,25]. This difference is likely to be the 
consequence of pathological fetal growth in the majority of preterm births. Therefore, 
reference ranges for BW contains an overrepresentation of pathological pregnancies 
particularly for gestational ages <37 weeks. Nicolaides and colleagues established a BW 
chart using fetuses still in utero, thereby overcoming the problem of underestimation of 
growth restriction in preterm birth [26]. Using the latter chart, the authors demonstrated 
that for preterm birth, BW was below the 10th centile in a very high proportion of cases 
(Figure 2) [26], both for iatrogenic causes (52.5%) and spontaneous preterm births 
(19.8%). The latter charts would seem the appropriate choice for screening for preterm 


































































Despite the apparent limitations, local and national charts are in wide usage across the 
world, even though it is not clear how multicultural populations are represented in such 
charts. An unresolved major issue that undermines the justification for the use of such 
charts is a believable biological explanation for how nationality/national borders influence 
fetal growth. 
Customized charts 
A potential approach to deal with the limitations of population-based local or national 
growth charts is customization, where expected fetal growth is modulated according to 
individual variables that are known to affect fetal growth [27]. Proponents of customized 
growth charts established the growth potential of each fetus according to physiological 
variations in maternal characteristics such as height, weight, ethnic origin, parity and fetal 
sex, but not for pathology such as premature birth, smoking, hypertensive disorders or 
diabetes [28-32]. It has been suggested customizing expected fetal growth for these 
variables will result in improved diagnosis of SGA pregnancies at risk of adverse outcome 
[33]. For instance, it has been suggested that use of customised charts will reduce the 
number of pregnancies classified as SGA to approximately 10% when used in Asian or 
low BMI populations. The latter groups typically have much higher rates of SGA when 
classified using population-based fetal growth charts, which supposedly identify ‘normally 
small’ rather than FGR babies as risk of adverse outcome. 
Whilst it is certainly true that certain maternal characteristic are associated with altered 
fetal growth, the very same variables also predispose to increased fetal morbidity and 
mortality. For example, customization ‘normalises’ smaller fetuses in Asian and Afro-
Caribbean women, when women from these ethnicities are also at increased risk of 
stillbirth [34]. Similarly, other variable used in customised fetal growth charts such as 
maternal age, weight and parity have also been shown to be related to risk of stillbirth 
[35,36]. Apart from the concern that customisation of fetal growth is ‘normalising’ for 
variables that predispose to pregnancy pathology, there is also the question of biological 
rationale for customisation. The well-accepted associations between these variables and 
fetal weight cannot be causative, as it is inconceivable that the 1-2% of genes that 


































































growth. Similarly, the placenta cannot ‘know’ the age of the mother, her weight or parity, 
making the latter variables proxy markers for uteroplacental dysfunction rather than 
directly controlling fetal growth [37]. 
Regardless of the justification for the use of customisation, it is important to recognise 
that customisation was proposed as a means of better identifying at-risk pregnancies. 
However, systematic evaluation of the use of customisation has failed to show increased 
performance in the detection of adverse pregnancy outcome in several large or 
prospectively conducted studies [38,39,40] 
International reference standard 
The popularity of local, national or customised fetal growth reference charts is based on 
the reasoning that approximately 10% of fetuses in any given population should be SGA. 
This assumption is fundamentally at odds with the known variation in rates of neonatal 
malnutrition at birth worldwide (Figure 3) ranging from as high as 27% in South Asia to a 
low of 7% in Europe [41]. This variation in malnutrition at birth is attributed to differences 
in nutrition, maternal co-morbidity and other socioeconomic factors – and is used as 
justification by proponents of an international fetal growth reference standard [23,42]. 
Fetal growth reference standards are prescriptive charts that are constructed 
prospectively in populations that have been screened before recruitment to ensure 
minimal bias from detrimental environmental and medical confounders that may affect 
fetal growth. So as opposed to retrospective local or national charts that describe how 
fetuses in a certain population have grown, fetal growth reference standards describe 
how fetuses should grow if they were free of any environmental or clinical constraints. 
Two consortiums used this approach to define optimal fetal growth reference standards 
[23, 43]. The Intergrowth-21st consortium adapted the same stringent standards to control 
for environmental and medical confounders as was used for the well-established WHO 
Child Growth Standards [44]. Intergrowth-21st showed that human growth in low risk 
environments is very similar in fetuses regardless of where they live or their ethnic/racial 
background [23]. These findings would suggest that perinatal health and fetal growth are 
mainly affected by the environmental, nutritional, socioeconomic factors across 


































































hospital, which introduced bias as it does not necessarily remove environmental 
constraints [23]. The NICHD study showed that fetal growth was minimally – but 
significantly different in four self-reported ethnic groups [43]. Interestingly, the NICHD 
study also demonstrated that marital status, level of education, annual income and private 
insurance influenced fetal growth. 
Retrospective evaluations of the Intergrowth-21 fetal growth reference standard in two 
large population studies concluded that there was a reduced identification of SGA fetuses 
and cases of perinatal death [45, 46]. It should be noted that the poorer performance of 
the Intergrowth-21 reference standards was for a much lower number of pregnancies 
classified as SGA. Neither of the studies provided a comparison of screening efficiency 
for adverse outcome at comparable screen positive rates – which would have provided a 
better head-to-head comparison of different growth references and standards. 
 
SHOULD WE ASSESS FETAL GROWTH INSTEAD OF FETAL SIZE? 
Fetal growth - the relative change in fetal size over a time period - is often used as an 
alternative indicator of fetal wellbeing in screening programs using serial ultrasound 
assessment. Many clinicians believe that assessment of fetal growth over two or more 
scans is superior to assessment of fetal size alone, especially with the current uncertainty 
over which charts to use and whether to customise fetal size assessment by correcting 
for certain maternal characteristics. Although fetal growth can be objectively assessed by 
measuring change in fetal weight centile over the interval between scans, how this data 
should be interpreted is yet to be resolved. There are no evidenced-based guidelines that 
outline the risk of adverse outcome based on i) change in fetal weight centile, ii) over the 
interval of fetal growth assessment and iii) whether the same change in growth implies 
similar risks at different gestations. For example, is a 20% drop in fetal weight centile over 
a two-week interval clinically significant and is this significance similar at 28, 32 and 36 
weeks’ gestation? Thresholds for intervention on the basis of pathological deviation in 
fetal growth are likely to depend on gestational age at onset of placental insufficiency, as 


































































endure such compromise. It would be churlish to assume that a given fetal growth 
threshold could serve to identify and prevent stillbirth at any given gestation. 
In a large randomised controlled trial of early-onset fetal growth restriction <32 weeks, 
the TRUFFLE investigators demonstrated that fetal growth velocity did not help predict or 
prevent adverse outcome [47]. Similarly, in late pregnancy, the POP study in which 
women were allocated to either routine pregnancy care or serial (clinically blinded) 
ultrasound scans, fetal growth velocity was significantly associated with adverse 
outcome, but only in the SGA fetuses and not in appropriate‐for‐gestational‐age births 
[48]. Several retrospective but larger studies have also shown that growth velocity does 
not improve prediction of adverse pregnancy outcome due to placental dysfunction [49-
51] . The authors also demonstrated that the lack of clinical benefit from assessing fetal 
growth held true for whether the inter-scan interval was large (from 20 to 36 weeks) or 
small (from 32 to 36 weeks). 
 
DOES ASSESSMENT OF FETAL SIZE REDUCE STILLBIRTH AT TERM? 
The prevalent clinical focus on routinely monitoring fetal size is predicated on the 
association with stillbirth and the desire to deliver the pregnancy before this adverse 
outcome occurs. However, unlike preterm stillbirth where the majority of stillborn are SGA, 
intrauterine demise at term occurs in appropriately grown fetuses in 60–70% of cases 
(Figure 4) [52]. More recently, it has become evident that after a stillbirth, fetuses lose 
approximately 20% of their bodyweight through intrauterine maceration before birth and 
dehydration ex-utero before having their weight formally recorded [53]. Therefore, the 30-
40% of term stillbirths that are classified as SGA were probably incorrectly classified with 
a significant proportion being AGA at the time of intrauterine demise. Whilst it is not in 
doubt that there is an association between SGA and stillbirth, it is clear that a health policy 
focused entirely on identification of SGA fetuses not prevent the majority of stillbirths at 
term. The latter is supported by population studies such as by Monier and colleagues [54] 
in a population-based study of routine third-trimester ultrasound in 14,000 pregnancies 
detected only 21.7% of SGA infants and resulted in a high false positive rate for SGA 


































































perinatal mortality. In a follow-up study of over 90,000 pregnancies, the same group 
reported a disappointing protective effect of SGA/FGR detection than previously reported 
as over 40% of stillbirths occurred despite detection of SGA [55]. In a prospective study 
of over 45,000 pregnancies, Akolekar and colleagues demonstrated that although in SGA 
babies had an increased risk of adverse perinatal outcome, 84% of adverse perinatal 
events occur in the AGA group – resulting in poor predictive performance of SGA 
detection for adverse perinatal outcome [56]. Both research groups called into question 
a focus solely on improving SGA detection without addressing post-detection 
management taking into account maternal characteristics, gestational age and Doppler 
assessment.  
 
EARLY AND LATER FETAL GROWTH RESTRICITON – TWO DIFFERENT 
DISORDERS? 
As well as reaching expert opinion on a definition of placental FGR a Delphi consensus 
has also been reached for both early and late-onset disease [57]. The underlying 
commonality between early and late gestation FGR is that they occur as a consequence 
of placental dysfunction. Both conditions are also associated with increased incidence of 
poor neurodevelopmental, cardiovascular and metabolic long-term outcomes for the 
affected fetus. Early FGR is less common and represents approximately 20-30% of all 
cases of growth restriction. It is associated with severe placental insufficiency and 
preeclampsia in up to 50% of cases. Late gestation FGR is more common and constitutes 
approximately 70-80% of all cases of growth restriction. It is associated with mild placental 
insufficiency and preeclampsia in approximately 10% of cases [58]. There is ongoing 
debate as to whether the placental dysfunction in late gestation FGR is a consequence 
of milder disease compared to early onset FGR or as a result of placental dysfunction 
occurring later in pregnancy.  
Our understanding of placental dysfunction is based on the fundamental assumption that 
the association between fetal size and adverse perinatal outcome is a causative one - 
that is to say that fetal smallness causes stillbirth. The placenta is responsible for multiple 


































































As such, placental dysfunction will confer both nutritional as well as respiratory 
consequences to the developing fetus [59]. It should be noted that failure to meet 
nutritional demands result in growth deficiency and can usually be tolerated for several 
few days/weeks, whereas failed respiratory function results in hypoxia which can only be 
tolerated for minutes/hours. Fetal nutritional needs follow a logarithmic curve (Figure 5) 
whilst respiratory demands show exponential growth [59, 60]. In early-onset placental 
dysfunction, fetal nutrition is compromised more severely than respiration, thereby 
predominantly resulting in growth restriction as the main presenting feature. At this early 
stage of pregnancy, fetal respiratory demands are low and usually continue to be met by 
a dysfunctional placenta for several weeks. The latter explains why in early-onset 
placental dysfunction, SGA develops over several weeks of nutritional insufficiency. In 
contrast, late onset of placental dysfunction at term will disproportionately affect fetal 
respiratory demands which are increasing exponentially at this stage of pregnancy, just 
as nutritional demands begin to plateau. Thus, a 3000g fetus near term that is affected 
by placental failure is likely to die from hypoxia related to respiratory dysfunction within a 
few days, long before it can become small from failing to grow over several weeks. 
Put simply, placental dysfunction a disorder which may manifest signs of either SGA from 
malnutrition or stillbirth from respiratory failure. The nutritional and respiratory demands 
of a fetus vary significantly with advancing gestation, and the consequences of either 
nutritional or respiratory compromise have different presentations (SGA versus stillbirth) 
and temporal patterns (protracted versus rapid). Early-onset placental dysfunction 
presents predominantly with SGA, whereas in late-onset disease, critical fetal hypoxia 
may occur in a term fetus before SGA has time to develop. 
 
MANAGEMENT OF LATE-ONSET PLACENTAL DYSFUNCTION 
It is not unsurprising given the issues surrounding fetal growth assessment, that there is 
real controversy and considerable variation in practice for the clinical management of late-
onset FGR/placental dysfunction. In spite of these concerns, a number of definitive 
management decisions can be justified.  


































































Requires the use of validated EFW formula that can be used in any clinical setting, such 
as those published by Hadlock et al. (1985) and Hammami A et al. (2018) using multiple 
fetal biometric measures. 
Establishing fetal weight centile 
In preterm pregnancies, charts established using fetuses still in utero to overcome the 
problem of underestimation of preterm growth restriction, such as developed by 
Nicolaides K et al. should be used [26]. Near term, irrespective of which charts are used, 
the majority of adverse pregnancy outcomes will occur in non-SGA pregnancies, hence 
the choice of fetal growth reference charts is unlikely to have a major clinical impact. This 
makes the case for use of an international fetal growth reference standard so that 
meaningful comparisons of SGA rates between countries and before/after birth can be 
made. 
Assessing fetal wellbeing 
In preterm pregnancies should include the use of computerised CTG and DV Doppler up 
to 32 weeks gestation along with indicated delivery for reversed end-diastolic umbilical 
artery blood flow from 32 weeks and for absent end-diastolic umbilical artery blood flow 
from 34 weeks [61]. Near term, even though the risk of stillbirth is increased in SGA 
pregnancies, the majority of stillbirths occur in normally sized babies. Cerebroplacental 
ratio (CPR) - the ratio of the middle cerebral artery pulsatility index to the umbilical artery 
pulsatility index - is emerging as a potentially useful marker of fetal hypoxemia at term 
[62, 63]. Low CPR is known to be a marker for fetal hypoxemia at term in AGA fetuses 
[49], and is associated with low abdominal circumference growth velocity and adverse 
pregnancy outcomes including stillbirth, neonatal unit admission and neonatal morbidity 
[49]. As the risk of perinatal mortality seems to increase only when EFW is below the 30th 
centile of birthweight for gestation (Figure 6) [39], the latter population would seem to be 
a reasonable target for fetal Doppler/CPR evaluation. Unfortunately, it is still not evident 
whether the use of fetal Doppler evaluation in this sub-population can prevent stillbirth 
and improve perinatal outcome. It is likely that combined evaluation of maternal 


































































algorithm may be of value in identifying pregnancies that justify earlier scheduled birth 
because of an increased risk of adverse outcome and [64, 65]. 
 
CONCLUSION 
Placental dysfunction is associated with fetal smallness due to intrauterine malnutrition 
as well as fetal disability and even death from respiratory hypoxemia. Fetal size is 
universally used as a common clinical proxy for placental dysfunction. The issue of which 
fetal weight centile assessment should be used continues to be a contentious topic. The 
arguments against local fetal growth charts based on national borders and customization 
for maternal variables associated with pregnancy pathology are considerable. As for other 
human diseases such as hypertension and diabetes, the rationale for the use of an 
international fetal growth reference standard makes a lot of sense. Variation in national 
rates of SGA is perceived as a limitation of these charts, but not when one considers that 
these variations are aligned to the rates of neonatal malnutrition seen in these countries. 
Irrespective of the choice of fetal growth reference standard, a significant limitation of 
national SGA detection programs to prevent stillbirth is that the majority of stillborn infants 
at term were not SGA at the time of demise. That placental dysfunction may present either 
with signs of SGA from malnutrition or stillbirth from hypoxemia is explained when one 
understands the varying fetal nutritional and respiratory demands with advancing 
gestation. Emerging data show consistently that fetal Doppler arterial redistribution is 
associated more strongly than fetal size with perinatal death at term. Properly conducted 
and powered trials of the role for maternal characteristics, fetal size, placental biomarkers 





































































 Accurately estimating fetal weight can be achieved by using validated 
multiparameter fetal biometry formulae 
 Establishing fetal weight centile can be undertaken using population/customised 
fetal growth references or international fetal growth standards 
 Population charts are limited by the lack of a believable biological explanation for 
how nationality or national borders influence fetal growth 
 Whilst certain maternal characteristics are associated with altered fetal growth, the 
very same variables also predispose to increased fetal mortality questioning the 
rationale for customisation. 
 Stillbirth prevention policies based identifying SGA fetuses are significantly limited 
by the finding that at term, the majority of antenatal stillbirths are appropriately 
grown at the time of intrauterine demise 
 Fetal Doppler arterial redistribution is more strongly associated with perinatal death 
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Figure 1 Association between birth weight and estimated fetal weight derived from model 
of Hadlock et al.21 using measurements of head circumference, abdominal circumference 
and femur length in the study population (r=0.959, p<0.0001). Reproduced with 
permission from Hammami A et al.20 
 
Figure 2 Percentage of cases in a cohort of 95,579 pregnancies with birth weight below 
3rd (clear bars), 5th (grey bars) and 10th (dark bars) percentiles of reference range of 
birth weight according to gestational age. Reproduced with permission from Nicolaides K 
et al.26 
 
Figure 3 Low birth weight prevalence by UNICEF regions. Taken from UNICEF-WHO low 
birth weight estimates 2019.41 
 
Figure 4 Birth weight according to gestational age at delivery in 436 pregnancies 
complicated by stillbirth, plotted against 10th, 50th and 90th percentiles of 112582 live births 
(solid lines) and those of the Intergrowth 21st standard (dotted lines). Reproduced with 
permission from Poon L et al. 52 
 
Figure 5 Increase in fetal nutrition (green line) and respiratory (red line) demands with 
advancing gestation. Early onset placental dysfunction (vertical gray solid line) will impact 
at a time when fetal nutritional demands (green arrows) rise exponentially and therefore 
will have a disproportionate effect on fetal growth compared with development of fetal 
hypoxemia and demise. Placental dysfunction at term (vertical gray dotted line) will impact 
at a time when fetal respiratory needs (red arrows) rise exponentially and therefore likely 
to compromise fetal wellbeing before fetal growth is impaired. Reproduced with 



































































Figure 6 Infant mortality and stillbirth according to birthweight centiles. Reproduced with 
permission from Iliodromiti S et al. 39 
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